Matritech Files Compliance Plan with AMEX (Business Wire via Yahoo! Finance)
NEWTON, Mass.----Matritech , a leading marketer and developer of protein-based diagnostic products for the early detection of cancer, today announced that it has filed a plan with the American Stock Exchange outlining the actions it proposes to take to bring it into compliance no later than March 21, 2008 with AMEX's continued listing standards.

NeuroMetrix, Inc. Signs Exclusive Licensing Agreement with EyeTel Imaging, Inc. for the Detection of Diabetic (Business Wire via Yahoo! Finance)
WALTHAM, Mass.----NeuroMetrix, Inc. , a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, including diabetic peripheral neuropathy, announced today that it has signed an exclusive licensing agreement with EyeTel Imaging, Inc.